Oesophageal Adenocarcinomas: Where Do We Stand Today?
Oesophageal cancers (oesophageal squamous cell carcinomas and adenocarcinomas) haven been responsible for more than one million deaths worldwide in 2018 [...]
Main Authors: | Karl-Frederick Karstens, Björn Ole Stüben, Matthias Reeh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/1/109 |
Similar Items
-
Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
by: Chiara Villa
Published: (2020-11-01) -
Tumor Models and Drug Targeting In Vitro—Where Are We Today? Where Do We Go from Here?
by: Marcus Krüger, et al.
Published: (2023-03-01) -
Marine Compounds and Cancer: Where Do We Stand?
by: Sergey A. Dyshlovoy, et al.
Published: (2015-09-01) -
Dendrimers for Drug Delivery: Where Do We Stand in 2023?
by: Evgeny K. Apartsin
Published: (2023-12-01) -
Complementary Feeding in Preterm Infants: Where Do We Stand?
by: Maria Elisabetta Baldassarre, et al.
Published: (2020-04-01)